Fennec Pharmaceuticals price target raised to $19
Bullish analyst view, though the large implied upside is based on a single firm's target.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish analyst view, though the large implied upside is based on a single firm's target.
What happened, with direct paths to the underlying reporting
B. Riley raised its FENC price target to $19 from an indicated share price of $11.62, implying about 63% upside to the target. This is an analyst estimate, not a forecast guarantee.
Target: $19
Posted price: $11.62
Analyst firm: B.Riley Financial
Analyst: Madison El-Saadi
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.